Centre Hospitalier Universitaire Vaudois
Clinical trials sponsored by Centre Hospitalier Universitaire Vaudois, explained in plain language.
-
Can intense rehab boost stroke recovery? swiss study aims to find out.
Disease control Recruiting nowThis study tests whether a high-dose, high-intensity neurorehabilitation program is practical and helpful for adults recovering from a stroke. About 120 participants will receive up to 300 minutes of technology-supported training each week, in addition to standard care, across ho…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Pre-Surgery nutrition drink may cut infection risk in bladder operations
Disease control Recruiting nowThis study tests whether drinking a special nutritional supplement before bladder removal surgery (cystectomy) can reduce infections and other complications within 30 days. About 232 adults in Switzerland will take part, with half receiving the supplement and half receiving stand…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
Personalized cell therapy LauT-1 enters early human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called LauT-1 for people with advanced melanoma or sarcoma that has not responded to standard therapies. LauT-1 uses a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The main goals …
Phase: PHASE1 • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
Knee cartilage repair: your own cells could be the answer
Disease control Recruiting nowThis study tests a procedure that uses a patient's own cartilage cells to repair damaged knee cartilage. It involves 218 people aged 15 to 50 with specific knee defects. The goal is to see if this approach is safe and improves knee function and quality of life.
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC
-
Hope for recurrent brain tumors: Triple-Drug combo trial launches
Disease control Recruiting nowThis study tests a combination of three drugs (trimipramine, atezolizumab, and bevacizumab) in people whose glioblastoma brain tumor has come back after standard treatment. About 59 participants will receive the treatment for up to 2 years. The goal is to see if the combo can slo…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC
-
Your phone may soon check your blood pressure – no cuff needed!
Diagnosis Recruiting nowThis study explores whether a smartphone can reliably screen for high blood pressure by analyzing video recorded at your fingertip. About 100 adults will record their blood pressure using both a smartphone and a standard arm cuff, three times each morning and evening for a week. …
Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Diagnosis
Last updated Jun 16, 2026 22:35 UTC
-
Ultrasound-Guided numbing may reduce pain and opioid use in child circumcisions
Symptom relief Recruiting nowThis study tests whether using ultrasound to guide a numbing injection for circumcision works better than the standard method based on feel. About 216 boys under 18 will be randomly assigned to one of two groups. The goal is to see if ultrasound reduces the need for strong painki…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Symptom relief
Last updated Jun 12, 2026 12:08 UTC
-
AI predicts tough intubations: could save lives in surgery
Knowledge-focused Recruiting nowThis study aims to create a portable, radiation-free software that uses facial recognition and neck movement analysis to predict how difficult it will be to place a breathing tube during anesthesia. Researchers will enroll 1800 adults undergoing planned surgery to test the softwa…
Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:10 UTC